White label – Pompe disease - ClinicalTrials.eu

Safety and Tolerability of Intrathecal TRCN-1023 in Adults with Amyotrophic Lateral Sclerosis (ALS) – Randomized Placebo‑Controlled Phase 1/2 Trial

Recruiting

1 1
Investigated Diseases:
- Amyotrophic lateral sclerosis
A Phase 2a Study Evaluating the Efficacy and Safety of MK-8690 in Adults with Moderately to Severely Active Ulcerative Colitis

Recruiting

2 1
A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

Recruiting

3 1

+15
Long‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy

Recruiting

2 1 1
Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis

Recruiting

2 1 1 1
Investigated Drugs:
- Nemolizumab
+1
Phase I/II Study of AZD6621 Safety and Efficacy in Adult Men with Metastatic Prostate Cancer

Recruiting

2 1 1
Investigated Diseases:
- Prostate cancer metastatic
A Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer

Recruiting

3 1
Investigated Diseases:
- Non-small cell lung cancer stage I
Investigated Drugs:
- Mrna-4157
- Pembrolizumab
+2
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Recruiting

2 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- SPY002
+9
Effectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis

Recruiting

3 1 1 1
Investigated Diseases:
- Glomerulonephritis membranoproliferative
Investigated Drugs:
- Pegcetacoplan
Study of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)

Recruiting

3 1 1 1
Investigated Diseases:
- Oesophageal adenocarcinoma
- Gastric cancer
Investigated Drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies